National Technical Reports Library

The National Technical Information Service acquires, indexes, abstracts, and archives the largest collection of U.S. government-sponsored technical reports in existence. The NTRL offers online, free and open access to these authenticated government technical reports. Technical reports and documents in its repository may be available online for free either from the issuing federal agency, the U.S. Government Publishing Office’s Federal Digital System website, or through search engines.

Details

NIOSH Testimony on Recombinant DNA by A. Robbins, May 20, 1980.

PB90192931

Publication Date	1980
Page Count	10
Abstract	The testimony concerned the efforts of the National Institute for Occupational Safety and Health (NIOSH) to protect the health of workers involved with industrial applications of recombinant DNA techniques. The rapid growth of recombinant DNA technology in pharmaceutical, chemical, agricultural, energy and food processing facets of the economy indicated the need for careful evaluation of health risks to workers in these areas. A recent National Institute of Health workshop addressed the question of risks related to Escherichia-coli-K-12 production of insulin and human growth hormone. Those possibly exposed to recombinant DNA will include not only scientists, but also technicians, maintenance and custodial personnel. As there often has been a long latency period with occupational diseases, there is no assurance that just because no problems have been identified among the workers as yet that there are no problems there. Retrospective research was underway. NIOSH was also conducting on site studies of commercial facilities as they begin pilot operations and production. NIOSH also planned to evaluate the submission from private companies on large scale research or production made to the Recombinant DNA Advisory Committee. Recommendations which were made in 1977 to the Subcommittee on Health and the Environment were restated.
Keywords	Industrial medicine Risk Bioengineering Technology innovation Research Deoxyribonucleic acids Exposure Hazards Government policies Guidelines Occupational diseases Occupational safety and health Genetic engineering Testimony
Source Agency	National Institute for Occupational Safety and Health
NTIS Subject Category	57U - Public Health & Industrial Medicine 57F - Cytology, Genetics, & Molecular Biology 57Y - Toxicology 94D - Job Environment 41 - Manufacturing Technology
Corporate Authors	National Inst. for Occupational Safety and Health, Cincinnati, OH.
Document Type	Technical Report
NTIS Issue Number	199012

NIOSH Testimony on Recombinant DNA by A. Robbins, May 20, 1980.

NIOSH Testimony on Recombinant DNA by A. Robbins, May 20, 1980.
PB90192931

Publication Date	1980
Page Count	10
Abstract	The testimony concerned the efforts of the National Institute for Occupational Safety and Health (NIOSH) to protect the health of workers involved with industrial applications of recombinant DNA techniques. The rapid growth of recombinant DNA technology in pharmaceutical, chemical, agricultural, energy and food processing facets of the economy indicated the need for careful evaluation of health risks to workers in these areas. A recent National Institute of Health workshop addressed the question of risks related to Escherichia-coli-K-12 production of insulin and human growth hormone. Those possibly exposed to recombinant DNA will include not only scientists, but also technicians, maintenance and custodial personnel. As there often has been a long latency period with occupational diseases, there is no assurance that just because no problems have been identified among the workers as yet that there are no problems there. Retrospective research was underway. NIOSH was also conducting on site studies of commercial facilities as they begin pilot operations and production. NIOSH also planned to evaluate the submission from private companies on large scale research or production made to the Recombinant DNA Advisory Committee. Recommendations which were made in 1977 to the Subcommittee on Health and the Environment were restated.
Keywords	Industrial medicine Risk Bioengineering Technology innovation Research Deoxyribonucleic acids Exposure Hazards Government policies Guidelines Occupational diseases Occupational safety and health Genetic engineering Testimony
Source Agency	National Institute for Occupational Safety and Health
NTIS Subject Category	57U - Public Health & Industrial Medicine 57F - Cytology, Genetics, & Molecular Biology 57Y - Toxicology 94D - Job Environment 41 - Manufacturing Technology
Corporate Authors	National Inst. for Occupational Safety and Health, Cincinnati, OH.
Document Type	Technical Report
NTIS Issue Number	199012